Insurer and PBM tactics are shifting higher costs to patients with chronic and complex conditions

Health plans are increasingly using deductibles and coinsurance to shift more of the cost of care to chronically ill patients taking brand medicines. As data from IQVIA show, this alarming trend is especially burdensome for patients with cancer, who pay nearly 10X more on average per year for their medicines when they face deductibles and coinsurance versus patients with only fixed copays. 
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Health Insurance Pharmacy Benefit Managers Source Type: news